Presentation ACC 2023 A Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease (PCDS Statin) Presenter: Salim Virani March 05, 2023 REGISTER for free or LOG IN to view this content Clinical Cardiology Clinical Pharma Policy & Practice Presentation ACC 2023 Up Next Presentation ACC 2023 A Cluster-Randomized Trial to Improve Care of Patients in Cardiology Clinics with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease [COORDINATE-Diabetes] Presenter: Neha J. Pagidipati March 05, 2023 More slides + Presentation ACC 2023 Efficacy and Safety of the Oral PCSK9 Inhibitor, MK-0616, a Macrocyclic Peptide, in the Treatment of Hypercholesterolemia: A Phase 2b Randomized Placebo-Controlled Clinical Trial Presenter: Christie Ballantyne March 05, 2023 Presentation ACC 2023 Impact of Heart Failure Management Using Thoracic Fluid Monitoring From A Novel Wearable Sensor: Results of the Benefits of Microcor (μCor™) in Ambulatory Heart Failure (BMAD) Trial Presenter: John P. Boehmer March 05, 2023 We Recommend
Presentation ACC 2023 A Cluster-Randomized Trial to Improve Care of Patients in Cardiology Clinics with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease [COORDINATE-Diabetes] Presenter: Neha J. Pagidipati March 05, 2023
Presentation ACC 2023 Efficacy and Safety of the Oral PCSK9 Inhibitor, MK-0616, a Macrocyclic Peptide, in the Treatment of Hypercholesterolemia: A Phase 2b Randomized Placebo-Controlled Clinical Trial Presenter: Christie Ballantyne March 05, 2023
Presentation ACC 2023 Impact of Heart Failure Management Using Thoracic Fluid Monitoring From A Novel Wearable Sensor: Results of the Benefits of Microcor (μCor™) in Ambulatory Heart Failure (BMAD) Trial Presenter: John P. Boehmer March 05, 2023